For qualified laboratory research onlyNot for human or veterinary use
Metabolic / Reference standard
Tirzepatide 5 MG research productTirzepatide5 MG
5 MG · BOX OF 10

Metabolic collection

Tirzepatide

5 MG per vial · Box of 10

A dual GIP and GLP-1 receptor agonist studied for combined effects on appetite, insulin signaling, and fat metabolism.

Strength per vial5 MG
QuantityBox of 10
SKUQP-TIRZEPATIDE-5MG-BX10
DocumentationLot-linked records
$350.00
1

Secure checkout is available through PeptidePay and NOWPayments.

Product guide

About Tirzepatide

Approved medicine
01

What it is

A dual GIP and GLP-1 receptor agonist that combines two gut-hormone pathways involved in appetite, insulin signaling, and fat metabolism.

02

Research context

In SURMOUNT-1, the highest studied dose group had an average 20.9% weight reduction at 72 weeks, compared with 3.1% in the placebo group.

Research-use noticeThis catalogue summary is educational, not medical advice or a recommendation for use. For qualified laboratory research only—not for human, clinical, veterinary, or household use.

✓Item addedCart now has 0 items